Dong-A Buoys Female Care Portfolio With Bayer OTCs
This article was originally published in PharmAsia News
Executive Summary
In the first move by a South Korean pharma firm to acquire global brand drugs, Dong-A Pharm has taken over four oral contraceptive products from Bayer Korea to beef up its OTC business and female product portfolios.